	Colorcon and The Dow Chemical Company have agreed to broaden their existing Controlled Release Alliance to include Dow’s advanced technology-based pharmaceutical excipients, effective January 1, 2017. The Alliance, originally announced in July 2007, currently provides controlled-release technologies from Dow Pharma & Food Solutions, a business unit of Dow, to customers.

	The Alliance offers provides customized solutions, products, and support services for pharmaceutical product development. The portfolio will include controlled-release technologies METHOCEL CR Cellulose Ethers, ETHOCEL polymers, and POLYOX resins; and excipient technologies including AFFINISOL polymers for solubility enhancement, ENTERACT polymers for enteric tablet coatings, and DUOLITE and AMBERLITE ion exchange resins for controlled release and other applications.

	The addition of new technologies into the Alliance product portfolio expands the existing relationship between Colorcon and Dow and further enables formulation and development of fast-growing pharmaceutical applications, beyond the existing controlled release scope, the companies report in a press statement.

	The agreement also renews an innovation partnership, in which Colorcon and Dow collaborate on the development and commercialization of controlled-release excipients.

Development

Excipients

PharmTech News

Supplier News

Dow and Colorcon extend and broaden the scope of the Controlled Release Alliance.